• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IXU
Click for more information
7.69% 1.4¢

IXUP LIMITED - Charts / Financials

Market Cap $21.66M  ! watchlist Created with Sketch. Add to my watchlist
Technology Software - Application

IXUP Limited is an Australia-based technology company. The Company has a suite of... IXUP Limited is an Australia-based technology company. The Company has a suite of software products that facilitate the secure sharing and analysis of sensitive information using advanced security technology. Its Secure Data Collaboration Suite of products represents the missing key to organizations unlocking their information assets previously unable to be shared or commercialized due to concerns around privacy, cybersecurity, and compliance considerations. It operates in three geographic segments: Australia, the UK, and the U.S. It is also the developer and operator of BetStop - National Self Exclusion Register, under contract with the Commonwealth Government of Australia via the Australian Communications and Media Authority (ACMA). The IXUP platform uses homomorphic encryption at the cellular level and can run in-depth calculations and analysis on multiple data sets without ever needing to decrypt them. The IXUP preserves privacy by securing analytics with advanced encryption.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 03/10/2024 (20 minute delay) ?
Day
Open 1.3¢   Day High 1.4¢   Day Low 1.3¢
Daily Volume 631310
Bids   Sellers
Number Price Volume   Number Price Volume
2 1.3¢ 861048   1 1.4¢ 298100

Directors & Senior Management

Mr. Alastair Watson Chief Executive Officer
Mr. Matthew Johnson Chief Financial Officer
Mr. Warren Steven Chief Operating Officer
Dr. Paul Coe Chief Technology Officer
Mr. David J. Franks Joint Company Secretary
Mr. Julian Babarczy Non-Executive Chairman of the Board
Mr. Ian R. Penrose Non-Executive Director
Ms. Freya Smith Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
1.4¢ 		Change
0.001(7.69%) 		Mkt cap ! $21.66M
Open High Low Value Volume
1.3¢ 1.4¢ 1.3¢ $8.271K 631.3K

Buyers (Bids)

No. Vol. Price($)
2 861048 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 298100 1
View Market Depth
Last trade - 15.59pm 03/10/2024 (20 minute delay) ?
Last
1.4¢ 		  Change
0.001 ( 7.69 %)
Open High Low Volume
1.4¢ 1.4¢ 1.4¢ 66286
Last updated 15.59pm 03/10/2024 ?

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Firefly positioned for copper growth in Canada ahead of resource update Firefly Metals Ltd has reported drilling reports from its Green Bay copper-gold project in Newfoundland, ahead of a resource update
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20% Chariot has unveiled its vision for its US-based Black Mountain – aiming to fast-track its path to production by establishing a "pilot mine."
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.